Development of new plasmid DNA vaccine vectors with R1-based replicons

<p>Abstract</p> <p>Background</p> <p>There has been renewed interest in biopharmaceuticals based on plasmid DNA (pDNA) in recent years due to the approval of several veterinary DNA vaccines, on-going clinical trials of human pDNA-based therapies, and significant advance...

Full description

Bibliographic Details
Main Authors: Bower Diana M, Prather Kristala LJ
Format: Article
Published: BMC 2012-08-01
Series:Microbial Cell Factories
Online Access: